granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change
Consolidated financial statements Change Increase/(Decrease) For Three Months Period Ended 30 September 2017 2018 THB mm % THB mm % THB mm % Sale Revenue Revenue from selling product under Company’s trademark 1
–2021 Balance by Quarter Change Q2–21 Q1–21 Q2–20 Q2–21 VS Q1–21 Q2–21 VS Q2–20 (Million Baht: MB) (MB) % (MB) % Total revenue 2,081.2 1,824.2 1,187.6 257.0 14.1 893.6 75.2 Total operating expenses
with respect to the production costs convert to administration expenses. (5) Expense of income tax for the nine-months period ended September 30, 2017 and 2016 consisted of the followings: (Unit: Million
be acquired through exercising the right to purchase or convert per one unit of securities of such issue. 4 See Footnote 2. (Translation) -3- IV. Other agreements to result in additional acquisition of
of the former mutual funds or the transferred mutual funds who vote to merge or amalgamate the funds and the unitholders who intend to convert the investment units of such funds into the investment
. The repayment of principal shall be as follows: 1st year 10% 2nd year 15% 3rd year 20% 4th year 25% 5th year 30% 2. Yunnan Water (Hong Kong) Company Limited (YUNNAN) shall convert loan into an
scope of every five percent report to cover financial instruments issued by others, which entitles the holder to convert or demand delivery of securities issued by listed company, e.g., derivative warrant